2nd Quarter - Report
CAPITOL SOLUTIONS for AMGEN USA
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement and coverage issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS | Legislative Assistant, Rep. Strickland |
| DANIEL C TATE | Legislative Director, Rep. W.J. Billy Tauzin |
Health Issues HCR
H.R. 1956, To amend the Public Health Service Act to provide for the approval of similar biological products H.R. 1038, To provide for the licensing of comparable and interchangeable biological products H.R. 5629, To establish a pathway for licensure of biosimilar biological products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS | Legislative Assistant, Rep. Strickland |
| DANIEL C TATE | Legislative Director, Rep. W.J. Billy Tauzin |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.